Furthermore, noteworthy attention should be given to single nucleotide polymorphisms (SNPs), such as PNPLA3 and TM6SF2, which are intricately linked to the onset and progression of MASLD. Here, TM6SF2 is linked to metabolic dysfunction-associated steatotic liver disease.